A computer analysis identified a tiny RNA molecule, or microRNA, as a potential therapeutic target to halt the progression of…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
A radioactive molecule that can be seen on positron emission tomography (PET) scans may offer a non-invasive way to identify…
The U.S. Food and Drug Administration (FDA) has accepted United Therapeutics’ application for…
Scientists found that mesenchymal stromal cells (MSCs) — cells that have similar properties to stem cells — individually…
Scientists have found a small molecule, called ISRIB, that was able to reduce fibrosis (scarring) and other disease-related…
Veracyte has presented new data demonstrating the diagnostic performance and utility of its…
While receiving treatment at specialized centers lowers the risk of hospitalization among patients with idiopathic pulmonary fibrosis (IPF), being…
Scientists discovered that blocking a tiny RNA molecule can help rejuvenate aged mesenchymal stem cells (MSCs) — which have the…
United Therapeutics has submitted a new drug application (NDA) to the U.S. Food and Drug…
Lassen Therapeutics and researchers at Cedars Sinai Medical Center in…